S STANDARD BIOTOOLS INC
| Market Cap | $354.15M |
| P/E Ratio | — |
| Forward P/E | -30.26 |
| Dividend Yield | — |
| Beta | 1.42 |
| 52W Range | $0.90 - $1.68 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Medical Devices |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Viking Global Investors Viking Global Investors | 0.20% | $75.07M | 58,651,170 | — |
Insider Trading
| Insider Name of the company insider who made the trade 15 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Casdin Partners Master Fund, L.P.Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director/ Director/ Director/ Director/ Director, 10% Owner | Buy | 150,000 | $1.45 | $217.02K | 04 Dec 2025 | 04 Dec 2025 |
| Casdin Partners Master Fund, L.P.Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director/ Director/ Director/ Director/ Director, 10% Owner | Buy | 75,000 | $1.44 | $108.04K | 03 Dec 2025 | 04 Dec 2025 |
| Casdin Partners Master Fund, L.P.Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director/ Director/ Director/ Director/ Director, 10% Owner | Buy | 125,000 | $1.42 | $177.51K | 02 Dec 2025 | 04 Dec 2025 |
| Casdin Partners Master Fund, L.P.Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director/ Director/ Director/ Director | Buy | 7,550,000 | $1.30 | $9.84M | 25 Nov 2025 | 26 Nov 2025 |
| Casdin Partners Master Fund, L.P.Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director/ Director/ Director/ Director | Buy | 150,000 | $1.43 | $214.88K | 24 Nov 2025 | 26 Nov 2025 |
| Casdin Partners Master Fund, L.P.Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director/ Director/ Director/ Director/ Director, 10% Owner | Buy | 450,000 | $1.30 | $586.26K | 20 Nov 2025 | 20 Nov 2025 |
| Casdin Partners Master Fund, L.P.Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director/ Director/ Director/ Director/ Director, 10% Owner | Buy | 350,000 | $1.28 | $448.91K | 19 Nov 2025 | 20 Nov 2025 |
| Casdin Partners Master Fund, L.P.Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director/ Director/ Director/ Director/ Director, 10% Owner | Buy | 275,000 | $1.23 | $339.40K | 18 Nov 2025 | 20 Nov 2025 |
| Casdin Partners Master Fund, L.P. | Buy | 225,000 | $1.22 | $275.58K | 17 Nov 2025 | 17 Nov 2025 |
| Casdin Partners Master Fund, L.P. | Buy | 250,000 | $1.24 | $309.80K | 14 Nov 2025 | 17 Nov 2025 |
| Casdin Partners Master Fund, L.P. | Buy | 450,000 | $1.20 | $541.39K | 13 Nov 2025 | 17 Nov 2025 |
| Casdin Partners Master Fund, L.P. | Buy | 375,000 | $1.19 | $445.84K | 12 Nov 2025 | 12 Nov 2025 |
| Casdin Partners Master Fund, L.P. | Buy | 300,000 | $1.20 | $358.80K | 11 Nov 2025 | 12 Nov 2025 |
| Casdin Partners Master Fund, L.P. | Buy | 275,000 | $1.17 | $321.92K | 10 Nov 2025 | 12 Nov 2025 |
| Casdin Partners Master Fund, L.P. | Buy | 225,000 | $1.12 | $252.76K | 07 Nov 2025 | 12 Nov 2025 |
Frequently Asked Questions
What is LAB stock price today?
STANDARD BIOTOOLS INC (LAB) is currently trading at $0.91. The stock has a 52-week range of $0.90 to $1.68 and a market capitalization of $354.15M.
Is LAB a good stock to buy in 2026?
STANDARD BIOTOOLS INC has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of -15.0%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling LAB stock?
There have been 15 insider transactions for LAB in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has LAB stock performed over the past year?
STANDARD BIOTOOLS INC (LAB) has returned -15.0% over the past 12 months. The stock traded between $0.90 and $1.68 during this period, and is currently at $0.91.
Which hedge funds own LAB (STANDARD BIOTOOLS INC)?
1 tracked hedge funds currently hold LAB in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is LAB's market cap and valuation?
STANDARD BIOTOOLS INC (LAB) has a market capitalization of $354.15M. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is LAB's revenue and profitability?
STANDARD BIOTOOLS INC reported revenue of $85.33M with net income of N/A and a profit margin of N/A. The stock has a beta of 1.42.
What sector is LAB in and who are its biggest institutional holders?
STANDARD BIOTOOLS INC (LAB) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.